- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06240169
Effect of Age on the Success of DPC Using Bio-ceramic Materials in Cariously Exposed Teeth With Reversible Pulpitis
Effect of Age on the Success of Direct Pulp Capping Using Bio-ceramic Materials in Cariously Exposed Teeth With Reversible Pulpitis: A Prospective Clinical Study.
Study Title: - Effect of age on the success of direct pulp capping using bio-ceramic materials in cariously exposed teeth with reversible pulpitis: A Prospective clinical study.
Rationale: - Preservation of pulp vitality is a critical factor in long-term tooth survival. In deep carious lesion with reversible pulpitis, vital pulp therapy procedures in the form of direct pulp capping(DPC)is more conservative treatment strategy, based on the premise that a biologically active material placed in direct contact with the pulp wound can determine the pulpal response and result in the development of a reparative hard tissue bridge to preserve pulp vitality. Patient's age may have a role in the survival rate after direct pulp capping and the role of the pulp capping material has been recognized as an important parameter for the success of treatment.
Research Question : Does age has any influence on the success of DPC procedure and is there any difference between MTA and Biodentine as DPC material in cariously exposed permanent teeth with reversible pulpitis? Aim & Objectives- To evaluate the effect of age on success of Direct Pulp Capping, to evaluate the success of MTA and Biodentine as direct pulp capping agents.
Study Overview
Status
Conditions
Detailed Description
Study Title: - Effect of age on the success of direct pulp capping using bio-ceramic materials in cariously exposed teeth with reversible pulpitis: A Prospective clinical study.
Rationale: - Preservation of pulp vitality is a critical factor in long-term tooth survival. In deep carious lesion with reversible pulpitis, vital pulp therapy procedures in the form of direct pulp capping(DPC)is more conservative treatment strategy, based on the premise that a biologically active material placed in direct contact with the pulp wound can determine the pulpal response and result in the development of a reparative hard tissue bridge to preserve pulp vitality. Patient's age may have a role in the survival rate after direct pulp capping and the role of the pulp capping material has been recognized as an important parameter for the success of treatment.
Research Question : Does age has any influence on the success of DPC procedure and is there any difference between MTA and Biodentine as DPC material in cariously exposed permanent teeth with reversible pulpitis? Aim & Objectives- To evaluate the effect of age on success of Direct Pulp Capping, to evaluate the success of MTA and Biodentine as direct pulp capping agents based on clinical and radiographic findings and assessment of post operative pain for 7 days post treatment.
Statistical method: - Data analysis by suitable statistical method.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Haryana
-
Rohtak, Haryana, India, 124001
- PGIDS
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Healthy patients (ASA I and ASA II).
- Patients falling in the age group of 18-60 years.
- Restorable permanent mandibular posterior teeth.
- Extremely deep caries penetrating the entire thickness of dentine and exhibiting signs and symptoms of reversible pulpitis.
- Teeth responding positively to cold test and electric pulp testing with no tenderness on percussion.
Exclusion Criteria:
- Primary teeth.
- Traumatic or mechanical exposure.
- No pulp exposure after caries excavation.
- Hemostasis not achieved within 10 mins.
- Teeth with irreversible pulpitis.
- Presence of periapical lesion or evidence of internal or external resorption, calcified canals, as assessed by radiographic examination.
- Patients with periodontal disease, swelling and sinus tract.
- Immunocompromised or pregnant patients, patients with any systemic disease, and a positive history of antibiotic use within 1 month and analgesic use within week before the treatment.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: DPC in AGE I with MTA
DPC using MTA in Age group I i.e. 18-40years.
|
DPC using MTA in 18-40 years
|
Experimental: DPC in AGE I with BD
DPC using BD in Age group I i.e. 18-40years.
|
DPC using BD in 18-40 years
|
Experimental: DPC in AGE II with MTA
DPC using MTA in Age group II i.e. 41-60years
|
DPC using MTA in 41-60Years
|
Experimental: DPC in AGE II with BD
DPC using BD in Age group II i.e. 41-60years
|
DPC using BD in 41-60Years
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
clinical and radiographic success rates and evaluation of the effect of age on the success of procedure.
Time Frame: Baseline to 18 months
|
CLINICAL SUCCESS CRITERIA
RADIOGRAPHIC SUCCESS CRITERIA
Also, to evaluate the effect of age on the success of procedure. |
Baseline to 18 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Post operative pain Secondary outcome measure will be pain intensity after treatment. Secondary outcome measure will be pain intensity after treatment. Secondary outcome measure will be pain intensity after treatment.
Time Frame: Base line to 7 days
|
To assess incidence and intensity of pain postoperatively at every 24 hours till 7 days using Visual analogue Scale of 0 to 100 millimeter line.
Score 0 means no pain and Score 100 means maximum pain To assess incidence and intensity of pain postoperatively at every 24 hours till 7 days using Visual analogue Scale of 0 to 100 millimeter line.
Score 0 means no pain and Score 100 means maximum pain
|
Base line to 7 days
|
Collaborators and Investigators
Investigators
- Principal Investigator: Sanjay Tewari, Pgids Rohtak
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Harshita Wadhwa
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pulpitis Reversible
-
Jordan University of Science and TechnologyActive, not recruitingDeep Caries | Irreversible Pulpitis | Reversible PulpitisJordan
-
Ain Shams UniversityCompleted
-
Ain Shams UniversityCompleted
-
King's College LondonUnknownReversible Pulpitis
-
Postgraduate Institute of Dental Sciences RohtakCompleted
-
Postgraduate Institute of Dental Sciences RohtakCompletedReversible Pulpitis
-
Cairo UniversityNot yet recruiting
-
Ege UniversityCompletedReversible PulpitisTurkey
-
Postgraduate Institute of Dental Sciences RohtakUnknownReversible PulpitisIndia
-
King's College LondonUnknownReversible PulpitisUnited Kingdom
Clinical Trials on DPC with MTA in AGEI
-
Hadassah Medical OrganizationCompletedPulpotomies Primary Teeth | Effectiveness of MedCem MTA® in Pulpotomies Primary TeethIsrael
-
Merve Erkmen AlmazCompleted
-
Ain Shams UniversityActive, not recruiting
-
Ain Shams UniversityCompleted
-
HK inno.N CorporationCompletedHealthyKorea, Republic of
-
Postgraduate Institute of Dental Sciences RohtakCompletedReversible Pulpitis
-
The Hong Kong Polytechnic UniversityHarvard Medical School (HMS and HSDM); Chinese University of Hong KongUnknown
-
Royan InstituteCompleted
-
University of Missouri-ColumbiaUnited States Department of DefenseRecruitingAutism Spectrum Disorder | Insomnia ChronicUnited States
-
Università degli Studi di SassariDr. Dario Melodia; Dr. Milena Pisano; Prof. Silvio Mario Meloni; Prof. Edoardo... and other collaboratorsNot yet recruitingDental Implant | Dental Implant-Abutment DesignItaly